Windtree Therapeutics Receives SBIR Grant for Aerosolized KL4 Surfactant Devt
Windtree Therapeutics has received $1 million in federal funds to continue to develop an aerosolized KL4 surfactant as a potential drug to prevent radiation-induced lung injuries. The funds represent the third tranche of a $3 million Phase II Small Business Innovation Research grant the U.S. government awarded to the biotechnology company, Windtree said Thursday. Windtree noted it […] More